These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 3313681)

  • 21. Prevention of emergence of bacterial resistance with the combination of sulphamethoxazole and trimethoprim.
    Grüneberg RN; Emmerson AM
    Eur J Clin Microbiol; 1982 Jun; 1(3):155-8. PubMed ID: 6756907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial resistance of bacterial enteropathogens isolated from stools in Madagascar.
    Randrianirina F; Ratsima EH; Ramparany L; Randremanana R; Rakotonirina HC; Andriamanantena T; Rakotomanana F; Rajatonirina S; Richard V; Talarmin A
    BMC Infect Dis; 2014 Feb; 14():104. PubMed ID: 24568189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity of eight antibiotics against Salmonella and Shigella species.
    Arman D; Willke A; Tural D
    Eur J Epidemiol; 1994 Jun; 10(3):345-7. PubMed ID: 7859848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of bacterial pathogens associated with acute diarrhea in children under 5 years of age: a hospital-based cross-sectional study.
    Tian L; Zhu X; Chen Z; Liu W; Li S; Yu W; Zhang W; Xiang X; Sun Z
    BMC Infect Dis; 2016 Jun; 16():253. PubMed ID: 27267601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotic resistance among Shigella species isolated in Tehran, Iran.
    Nikkah J; Mehr-Movahead A
    Ann Trop Med Parasitol; 1988 Oct; 82(5):481-3. PubMed ID: 3077023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Susceptibility of recent Shigella isolates to mecillinam, ampicillin, tetracycline, chloramphenicol, and cotrimoxazole.
    Uwaydah M; Osseiran M
    J Antimicrob Chemother; 1981 Jun; 7(6):619-22. PubMed ID: 6972941
    [No Abstract]   [Full Text] [Related]  

  • 27. The comparative activity of pefloxacin, enoxacin, ciprofloxacin and 13 other antimicrobial agents against enteropathogenic microorganisms.
    Vanhoof R; Hubrechts JM; Roebben E; Nyssen HJ; Nulens E; Leger J; De Schepper N
    Infection; 1986; 14(6):294-8. PubMed ID: 3546145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trimethoprim resistance and single-agent use.
    Maskell R; Pead L
    Lancet; 1989 Sep; 2(8662):557-8. PubMed ID: 2570249
    [No Abstract]   [Full Text] [Related]  

  • 29. High prevalence of non-epidemic Shigella sonnei resistant to co-trimoxazole.
    Palenque E; Otero JR; Noriega AR
    J Antimicrob Chemother; 1983 Feb; 11(2):196-8. PubMed ID: 6339462
    [No Abstract]   [Full Text] [Related]  

  • 30. [Antibacterial activity in vitro and in vivo of the trimethoprim-sulphamethoxazole combination].
    Renzini G; Ravagnan G; Bormioli P; D'Alessandro A
    Antibiotica; 1969 Dec; 7(4):250-68. PubMed ID: 5004706
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparative in vitro activities of ten antimicrobial agents against bacterial enteropathogens.
    Carlson JR; Thornton SA; DuPont HL; West AH; Mathewson JJ
    Antimicrob Agents Chemother; 1983 Oct; 24(4):509-13. PubMed ID: 6651278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sulfamethoxazole-trimethoprim-resistant Shigella flexneri in northeastern Brazil.
    Tiemens KM; Shipley PL; Correia RA; Shields DS; Guerrant RL
    Antimicrob Agents Chemother; 1984 May; 25(5):653-4. PubMed ID: 6375563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trimethoprim/sulphamethoxazole resistance in Escherichia coli and Klebsiella spp. urinary isolates.
    Obaseiki-Ebor EE
    Afr J Med Med Sci; 1988 Sep; 17(3):175-9. PubMed ID: 2845759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolution of antimicrobial resistance in enteroaggregative Escherichia coli and enterotoxigenic Escherichia coli causing traveller's diarrhoea.
    Mendez Arancibia E; Pitart C; Ruiz J; Marco F; Gascón J; Vila J
    J Antimicrob Chemother; 2009 Aug; 64(2):343-7. PubMed ID: 19474067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistance of urinary tract isolates of Escherichia coli to trimethoprim, cotrimoxazole and ampicillin.
    Bailey RR; Peddie BA
    N Z Med J; 1988 Apr; 101(844):216-7. PubMed ID: 3283613
    [No Abstract]   [Full Text] [Related]  

  • 36. Antibiotic sensitivity of enteropathogenic Escherichia coli to mecillinam, trimethoprim-sulfamethoxazole and other antibiotics.
    Thorén A
    Acta Pathol Microbiol Scand B; 1980 Oct; 88(5):265-8. PubMed ID: 6258383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and antimicrobial resistance of bacterial enteropathogens in Crete, Greece, during 2011-2022.
    Maraki S; Mavromanolaki VE; Stafylaki D; Iliaki-Giannakoudaki E; Kasimati A
    Acta Microbiol Immunol Hung; 2024 Mar; 71(1):69-75. PubMed ID: 38345622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transferable resistance to trimethoprim in enteric pathogens isolated in Kuwait.
    Chugh TD
    J Hyg (Lond); 1985 Oct; 95(2):391-5. PubMed ID: 3905958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of isolation of Escherichia coli in blood cultures by trimethoprim-sulfamethoxazole.
    Hackbarth CJ; Ernst JD; Sande MA
    J Infect Dis; 1983 May; 147(5):964-5. PubMed ID: 6341486
    [No Abstract]   [Full Text] [Related]  

  • 40. Prevention of travelers' diarrhea with trimethoprim-sulfamethoxazole.
    DuPont HL; Evans DG; Rios N; Cabada FJ; Evans DJ; DuPont MW
    Rev Infect Dis; 1982; 4(2):533-9. PubMed ID: 7051246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.